Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) 2, CHEK2 and NBN genes,
potentially pathogenic genetic variants in new breast and ovarian cancer
RNAs in the pathogenesis of glial brain tumors, as well as the
potential use of miRNAs as diagnostic and therapeutic
Beilerli, Aferin,
Begliarzade, Sema,
Sufianov, Albert,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal (2022) . The
potential of circulating circular RNAs (circRNAs) as non-invasive biomarkers of various tumors has been
Yanchao, L.,
Sibin, Z.,
Gareev, I.,
Huan, X.,
Junfei, Z.,
Chunyang, L.,
Beylerli, O.,
Sufianov, A.,
Chao, Y.,
Yuyan, G.,
Xun, X.,
Ahmad, A. (2022) patients, to clarify the common genes of both, and to identify common pathways and
potential drugs
two interatomic
potentials (Ti_EAM and Ti_MEAM). The eight DNVMs modeled with Ti_EAM
potential element base using simple and inexpensive materials can
potentially enable the development of novel
Beylerli, Ozal,
Beilerli, Aferin,
Shumadalova, Alina,
Wang, Xiaoxiong,
Yang, Mingchun,
Sun, Hanran,
Teng, Lei (2022) potential as drugs for the treatment of glioblastoma and are considered as
potential anticancer drugs